ATE252389T1 - Ein arzneimittel zur behandlung von fettleibigkeit und verbesserung des lipidmetabolismus - Google Patents
Ein arzneimittel zur behandlung von fettleibigkeit und verbesserung des lipidmetabolismusInfo
- Publication number
- ATE252389T1 ATE252389T1 AT98121049T AT98121049T ATE252389T1 AT E252389 T1 ATE252389 T1 AT E252389T1 AT 98121049 T AT98121049 T AT 98121049T AT 98121049 T AT98121049 T AT 98121049T AT E252389 T1 ATE252389 T1 AT E252389T1
- Authority
- AT
- Austria
- Prior art keywords
- ones
- lipid metabolism
- medicinal product
- treating obesity
- improving lipid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Child & Adolescent Psychology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Feed For Specific Animals (AREA)
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP30404997 | 1997-11-06 | ||
JP23814498A JP3873097B2 (ja) | 1997-11-06 | 1998-08-25 | 抗肥満剤及び脂質代謝改善剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE252389T1 true ATE252389T1 (de) | 2003-11-15 |
Family
ID=26533552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98121049T ATE252389T1 (de) | 1997-11-06 | 1998-11-06 | Ein arzneimittel zur behandlung von fettleibigkeit und verbesserung des lipidmetabolismus |
Country Status (6)
Country | Link |
---|---|
US (1) | US6046184A (de) |
EP (1) | EP0916342B1 (de) |
JP (1) | JP3873097B2 (de) |
AT (1) | ATE252389T1 (de) |
CA (1) | CA2253130C (de) |
DE (1) | DE69819110T2 (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6531462B2 (en) * | 1997-11-06 | 2003-03-11 | Riken | Medicament for treating obesity and improving lipid metabolism |
GB9923076D0 (en) * | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
HUP0101693A3 (en) * | 1998-03-26 | 2002-08-28 | Phytopharm Plc Godmanchester | Use of steroidal sapogenins and their derivatives for producing pharmaceutical compositions for the treatment of alzheimeirs disease |
GB9923078D0 (en) * | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
GB9923077D0 (en) * | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
GB0000228D0 (en) * | 2000-01-06 | 2000-03-01 | Phytopharm Plc | Fluoro substituted sapogenins and their use |
GB0107822D0 (en) * | 2001-03-28 | 2001-05-23 | Phytopharm Plc | Sapogenin derivatives their synthesis and use methods based upon their use |
JP3790686B2 (ja) * | 2001-08-03 | 2006-06-28 | 独立行政法人理化学研究所 | 血糖降下剤 |
CN102727501A (zh) * | 2002-03-27 | 2012-10-17 | 菲特法姆股份有限公司 | 皂角苷配基及其衍生物的用途 |
US20050130948A1 (en) * | 2002-03-27 | 2005-06-16 | Daryl Rees | Therapeutic methods and uses of sapogenins and their derivatives |
US20040018959A1 (en) * | 2002-05-02 | 2004-01-29 | Randall S. Hickle | System and methods of lipid removal from the body |
JP4404710B2 (ja) | 2004-07-14 | 2010-01-27 | 有限会社テクノフローラ | ステロールの5−エン−3−オン体の製造方法、及び分析方法 |
CN101212976B (zh) | 2005-09-22 | 2010-12-29 | 森永乳业株式会社 | 内脏脂肪蓄积抑制剂 |
WO2007034851A1 (ja) | 2005-09-22 | 2007-03-29 | Morinaga Milk Industry Co., Ltd. | 内臓脂肪蓄積抑制剤 |
EP1930013B1 (de) | 2005-09-30 | 2016-03-23 | Morinaga Milk Industry Co., Ltd. | Mittel zur verbesserung der insulin-resistenz |
CN101277705B (zh) | 2005-09-30 | 2013-05-01 | 森永乳业株式会社 | 用于改善胰岛素抗性的药剂 |
FR2914188B1 (fr) * | 2007-03-28 | 2012-06-22 | Trophos | Nouvelle composition a base d'oxime de cholest-4-en-3-one |
FR2924346B1 (fr) * | 2007-11-30 | 2010-02-19 | Inst Biophytis Sas | Utilisation de phytoecdysones dans la preparation d'une composition pour agir sur le syndrome metabolique. |
JP2011051939A (ja) * | 2009-09-02 | 2011-03-17 | Toyo Hakko:Kk | 血中hdlコレステロール上昇剤、並びにそれを含む飲食品添加剤、飲食品及び医薬 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2522328B1 (fr) * | 1982-03-01 | 1986-02-14 | Roussel Uclaf | Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments |
JPH0723310B2 (ja) * | 1986-03-03 | 1995-03-15 | 株式会社アドバンス | 強肝剤 |
IL94272A (en) * | 1989-05-11 | 1994-04-12 | Richter Gedeon Vegyeszet | History of A9 Acids - Hydroxy - 3 - Oxo - 4, 42) 52 (- Stigmestadian 62 - Oai, process for their preparation and pharmaceutical preparations containing them |
DE4004920C1 (de) * | 1990-02-16 | 1991-09-19 | Kanoldt Arzneimittel Gmbh, 8884 Hoechstaedt, De | |
US5264428A (en) * | 1990-02-16 | 1993-11-23 | Kanoldt Arzneimittel Gmbh | Use of stigmasta-4-en-3-one in the treatment of androgen dependent diseases |
JP3029907B2 (ja) * | 1991-12-20 | 2000-04-10 | 理化学研究所 | 抗肥満剤 |
IL105050A0 (en) * | 1992-03-27 | 1993-07-08 | Lilly Co Eli | Steroid derivatives |
JP3862295B2 (ja) * | 1993-09-30 | 2006-12-27 | 独立行政法人理化学研究所 | 抗肥満剤 |
JP3129367B2 (ja) * | 1993-10-08 | 2001-01-29 | 日本油脂株式会社 | 角化亢進抑制剤 |
AU8257898A (en) * | 1997-06-17 | 1999-01-04 | Rutgers, The State University Of New Jersey | Hypocholesterolemic compositions from bamboo shoots |
-
1998
- 1998-08-25 JP JP23814498A patent/JP3873097B2/ja not_active Expired - Fee Related
- 1998-11-05 US US09/186,158 patent/US6046184A/en not_active Expired - Lifetime
- 1998-11-06 EP EP98121049A patent/EP0916342B1/de not_active Expired - Lifetime
- 1998-11-06 AT AT98121049T patent/ATE252389T1/de not_active IP Right Cessation
- 1998-11-06 DE DE69819110T patent/DE69819110T2/de not_active Expired - Lifetime
- 1998-11-06 CA CA002253130A patent/CA2253130C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE69819110D1 (de) | 2003-11-27 |
DE69819110T2 (de) | 2004-07-15 |
JPH11193296A (ja) | 1999-07-21 |
US6046184A (en) | 2000-04-04 |
EP0916342B1 (de) | 2003-10-22 |
CA2253130C (en) | 2008-01-15 |
EP0916342A1 (de) | 1999-05-19 |
CA2253130A1 (en) | 1999-05-06 |
JP3873097B2 (ja) | 2007-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE252389T1 (de) | Ein arzneimittel zur behandlung von fettleibigkeit und verbesserung des lipidmetabolismus | |
ATE334668T1 (de) | Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen | |
DE60045550D1 (de) | Vorbeugung und behandlung von amyloidogenischen krankheiten | |
AU2002357311A1 (en) | Prevention and treatment of oxidative stress disorders by glutathione and phase ii detoxification enzymes | |
AP1398A (en) | Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives. | |
DE69428130T2 (de) | Verwendung von bcl-2 zur herstellung von arzneimitteln zur therapeutischen behandlung und verhinderung von krankheiten | |
FI972793A (fi) | Nebivololin käyttö antiaterogeenisenä aineena | |
HK1080459A1 (en) | Novel pyrimidineamide derivatives and the use thereof | |
DE69602412T2 (de) | Ophthalmische Zubereitung zur Behandlung oder Prävention von trockenem Auge und Krankheiten, die dadurch verursacht werden, enthaltend 12-Sulfodehydroabietsäure | |
DE69725879D1 (de) | VERWENDUNG VON p-AMINOPHENOLDERIVATEN ZUR HERSTELLUNG VON PHARMAZEUTISCHEN ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON NEURODEGENERATIVEN ERKRANKUNGEN | |
ATE157871T1 (de) | Arzneimittel zur therapeutischen und prophylaktischen behandlung von krankheiten, die durch hyperplasie der glatten muskelzellen bedingt sind | |
DE59609508D1 (de) | Konjugat enthaltend dtpa und albumin zur individuellen dosierung von arzneimitteln | |
ATE365549T1 (de) | Mittel gegen stressinduzierte krankheiten | |
BG105342A (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases | |
ATE225171T1 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
EP0744176A3 (de) | Arzneimittel zur Hemmung von Knochenschwund | |
DE69621786T2 (de) | Aminotetralinderivat zur behandlung von herzkreislauferkrankung | |
DE69526584T2 (de) | Verwendung von immunosuppressiva zur behandlung der schizophrenie | |
DE69930624D1 (de) | Arzneimittel für hinterstrangataxie und zusammensetzung zur behandlung von hinterstrangataxie | |
PL371551A1 (en) | Statin therapy for enhancing cognitive maintenance | |
DE60024969D1 (de) | 2-methyl-3-butenyl-1-pyrophosphorsäuresalze und mittel zur behandlung von lymphozyten | |
NZ268914A (en) | Use of efaroxan and derivatives to prepare medicaments for treating neurodegenerative diseases especially alzheimer's disease | |
DK0826373T3 (da) | Forebyggende middel mod postoperativ astigmatisme | |
FR2759586B1 (fr) | Medicament de type anticancereux comportant au moins a titre de principe actif du 1-alpha hydroxycalciferol ou alfacalcidol | |
IT1251993B (it) | Composizioni farmaceutiche ad uso orale,a base di esteri di gangliosidi,per il trattamento di neuropatie del sistema nervoso periferico |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |